Skip to main content
. 2022 Oct 20;5(10):e2237699. doi: 10.1001/jamanetworkopen.2022.37699

Figure 2. Overall Survival for Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Carboplatin.

Figure 2.

The solid lines were estimated by a parametric Weibull proportional hazards regression analysis for interval censored data, and the dotted lines were generated by an interval-censored Cox proportional hazard model. HR indicates hazard ratio.